Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...

Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.

Element Biosciences created a high-throughput benchtop device that can deliver a whole genome for $100 – half the price of ...

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...

A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant ...

A new ultra-high-throughput sequencing platform boosts output, speeds turnaround, and improves genome coverage. It reduces costs, broadens clinical applications, and accelerates large-scale genomics ...

Researchers use long-read genome sequencing to discover 33% more structural variants and 38% more tandem repeats linked to autism spectrum disorder.

Left: Imaging of lamin A/C structures in a physically expanded nucleus from an individual with progeria. Right: Same, but with 3D genomic reads overlaid in their original spatial locations, colored by ...

Falls Church, Va.-based Inova has teamed up with Danvers, Mass.-based Veritas Genetics to provide genome sequencing and interpretation in MyMap. MyMap integrates Veritas’ genome sequencing technology, ...

“The Genome Institute has been a pioneer of both Illumina technology and human whole-genome sequencing, particularly in the study of cancer genomics,” Fellis said. “Many of the world’s first cancer ...